Corcept Therapeutics

CORT • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $146,808 $135,405 $123,601 $117,715
Gross Profit 144,273 133,528 121,956 116,141
EBITDA 29,620 32,299 31,346 30,406
EBIT 29,500 31,669 31,177 29,583
Net Income 27,762 31,355 31,378 27,528
Net Change In Cash 146,808 135,405 123,601 117,715
Cost of Revenue -127,565
Free Cash Flow 23,756 5,887 52,872 42,184
Cash 149,750 135,551 111,800 172,377
Basic Shares 109,915 110,886 111,099 109,590

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $482,375 $401,858 $365,978 $353,874
Gross Profit 475,894 396,473 360,697 348,292
EBITDA 109,644 115,603 127,544 130,439
EBIT 107,282 112,634 124,477 128,202
Net Income 106,140 101,418 112,512 106,011
Net Change In Cash 482,375 401,858 365,978 353,874
Cost of Revenue 1,427 44,921
Free Cash Flow 126,900 119,910 167,423 150,732
Cash 135,551 436,619 335,812 476,892
Basic Shares 111,742 115,966 125,963 124,194

Earnings Calls

Quarter EPS
2024-03-31 $0.25
2023-12-31 $0.28
2023-09-30 $0.28
2023-06-30 $0.25